MedPath
TGA Approval

Fluzone Inactivated Trivalent Influenza Vaccine (Split Virion) - Influenza virus haemagglutinin, 45 mcg/ 0.5 mL, suspension for injection, syringe (446170)

446170

Fluzone Inactivated Trivalent Influenza Vaccine (Split Virion) - Influenza virus haemagglutinin, 45 mcg/ 0.5 mL, suspension for injection, syringe

Sanofi-Aventis Australia Pty Ltd

May 9, 2025

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/c348ef7958c00fc3a328a7c14e903a61.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/1184d764e86713efb80ff3d22ca9d7cf.pdf

Active Ingredients

Influenza virus haemagglutinin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fluzone Inactivated Trivalent Influenza Vaccine (Split Virion) - Influenza virus haemagglutinin, 45 mcg/ 0.5 mL, suspension for injection, syringe (446170) - TGA 批准文号 | MedPath